JP2017502667A5 - - Google Patents

Info

Publication number

JP2017502667A5

JP2017502667A5 JP2016543001A JP2016543001A JP2017502667A5 JP 2017502667 A5 JP2017502667 A5 JP 2017502667A5 JP 2016543001 A JP2016543001 A JP 2016543001A JP 2016543001 A JP2016543001 A JP 2016543001A JP 2017502667 A5 JP2017502667 A5 JP 2017502667A5

Authority

JP

Japan

Prior art keywords

antibody

fragment

seq

antibody fragment

vista

Prior art date

2014-12-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 55
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 55
• 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 28
• 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 24
• 206010028980 Neoplasm Diseases 0.000 claims 23
• 239000000203 mixture Substances 0.000 claims 20
• 201000011510 cancer Diseases 0.000 claims 18
• 239000008194 pharmaceutical composition Substances 0.000 claims 17
• 125000003275 alpha amino acid group Chemical group 0.000 claims 16
• 239000012634 fragment Substances 0.000 claims 12
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims 10
• 210000001744 T-lymphocyte Anatomy 0.000 claims 10
• 239000000427 antigen Substances 0.000 claims 9
• 102000036639 antigens Human genes 0.000 claims 9
• 108091007433 antigens Proteins 0.000 claims 9
• 210000004027 cell Anatomy 0.000 claims 9
• 230000028993 immune response Effects 0.000 claims 9
• 238000011282 treatment Methods 0.000 claims 9
• 230000006044 T cell activation Effects 0.000 claims 4
• 239000005557 antagonist Substances 0.000 claims 4
• 210000002798 bone marrow cell Anatomy 0.000 claims 4
• 102000057058 human VSIR Human genes 0.000 claims 4
• 208000032839 leukemia Diseases 0.000 claims 4
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 4
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 4
• 229960005486 vaccine Drugs 0.000 claims 4
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims 3
• 208000003837 Second Primary Neoplasms Diseases 0.000 claims 3
• 230000008512 biological response Effects 0.000 claims 3
• 230000006698 induction Effects 0.000 claims 3
• 201000005202 lung cancer Diseases 0.000 claims 3
• 208000020816 lung neoplasm Diseases 0.000 claims 3
• 238000004519 manufacturing process Methods 0.000 claims 3
• 238000000034 method Methods 0.000 claims 3
• 210000001616 monocyte Anatomy 0.000 claims 3
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 2
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 2
• 108090000695 Cytokines Proteins 0.000 claims 2
• 102000004127 Cytokines Human genes 0.000 claims 2
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 2
• 108091005804 Peptidases Proteins 0.000 claims 2
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
• 239000004365 Protease Substances 0.000 claims 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 2
• 230000005888 antibody-dependent cellular phagocytosis Effects 0.000 claims 2
• 239000003085 diluting agent Substances 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 2
• 230000002708 enhancing effect Effects 0.000 claims 2
• 239000013604 expression vector Substances 0.000 claims 2
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
• 230000036039 immunity Effects 0.000 claims 2
• 230000001939 inductive effect Effects 0.000 claims 2
• 208000003747 lymphoid leukemia Diseases 0.000 claims 2
• 108020004707 nucleic acids Proteins 0.000 claims 2
• 102000039446 nucleic acids Human genes 0.000 claims 2
• 150000007523 nucleic acids Chemical class 0.000 claims 2
• 238000011275 oncology therapy Methods 0.000 claims 2
• 230000004044 response Effects 0.000 claims 2
• 230000004614 tumor growth Effects 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
• 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 claims 1
• 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 claims 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
• 206010005003 Bladder cancer Diseases 0.000 claims 1
• 206010006187 Breast cancer Diseases 0.000 claims 1
• 208000026310 Breast neoplasm Diseases 0.000 claims 1
• 241000699802 Cricetulus griseus Species 0.000 claims 1
• 108010041986 DNA Vaccines Proteins 0.000 claims 1
• 229940021995 DNA vaccine Drugs 0.000 claims 1
• 102000004190 Enzymes Human genes 0.000 claims 1
• 108090000790 Enzymes Proteins 0.000 claims 1
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
• 208000006404 Large Granular Lymphocytic Leukemia Diseases 0.000 claims 1
• 206010023791 Large granular lymphocytosis Diseases 0.000 claims 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 claims 1
• 206010025323 Lymphomas Diseases 0.000 claims 1
• 241000124008 Mammalia Species 0.000 claims 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
• 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
• 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 claims 1
• 229940022005 RNA vaccine Drugs 0.000 claims 1
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
• 206010041067 Small cell lung cancer Diseases 0.000 claims 1
• 230000006052 T cell proliferation Effects 0.000 claims 1
• 230000005867 T cell response Effects 0.000 claims 1
• 201000008717 T-cell large granular lymphocyte leukemia Diseases 0.000 claims 1
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 claims 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
• 230000004913 activation Effects 0.000 claims 1
• 230000001154 acute effect Effects 0.000 claims 1
• 201000006966 adult T-cell leukemia Diseases 0.000 claims 1
• 125000000539 amino acid group Chemical group 0.000 claims 1
• 230000005975 antitumor immune response Effects 0.000 claims 1
• 210000003719 b-lymphocyte Anatomy 0.000 claims 1
• 229960001212 bacterial vaccine Drugs 0.000 claims 1
• 238000001815 biotherapy Methods 0.000 claims 1
• 238000002512 chemotherapy Methods 0.000 claims 1
• 230000001886 ciliary effect Effects 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 230000033581 fucosylation Effects 0.000 claims 1
• 230000002519 immonomodulatory effect Effects 0.000 claims 1
• 210000002865 immune cell Anatomy 0.000 claims 1
• 230000002401 inhibitory effect Effects 0.000 claims 1
• 230000005764 inhibitory process Effects 0.000 claims 1
• 210000000265 leukocyte Anatomy 0.000 claims 1
• 210000004698 lymphocyte Anatomy 0.000 claims 1
• 108700021021 mRNA Vaccine Proteins 0.000 claims 1
• 210000000066 myeloid cell Anatomy 0.000 claims 1
• 201000000050 myeloid neoplasm Diseases 0.000 claims 1
• 210000000581 natural killer T-cell Anatomy 0.000 claims 1
• 210000000440 neutrophil Anatomy 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 229940023041 peptide vaccine Drugs 0.000 claims 1
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 229940023143 protein vaccine Drugs 0.000 claims 1
• 238000001959 radiotherapy Methods 0.000 claims 1
• 230000001105 regulatory effect Effects 0.000 claims 1
• 230000028327 secretion Effects 0.000 claims 1
• 238000001356 surgical procedure Methods 0.000 claims 1
• 230000004083 survival effect Effects 0.000 claims 1
• 238000002626 targeted therapy Methods 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 210000004881 tumor cell Anatomy 0.000 claims 1
• 201000005112 urinary bladder cancer Diseases 0.000 claims 1
• 229940023147 viral vector vaccine Drugs 0.000 claims 1
• 230000003442 weekly effect Effects 0.000 claims 1